T. V. Martynyuk

RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Gérald Simonneau, Andrea Maria D’Armini, Peter F. Fedullo et al. · The Lancet Respiratory Medicine · 2017 · 264 citations

Medicine, Internal Medicine, Pharmacotherapy +11

EURASIAN CLINICAL GUIDELINES ON DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION

I. E. Chazova, T. V. Martynyuk, А. S. Galyavich et al. · Eurasian heart journal · 2020 · 73 citations · Full text

Medicine, Internal Medicine, Hemodynamic Management +8

Pulmonary Artery Denervation for Patients With Residual Pulmonary Hypertension After Pulmonary Endarterectomy

Alexander Romanov, Alexander Cherniavskiy, Nataliya Novikova et al. · Journal of the American College of Cardiology · 2020 · 69 citations

Medicine, Cardiology, Surgery +8

2024 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension

А. S. Galyavich, Sergey V. Gorbachevsky, V. V. Gramovich et al. · Russian Journal of Cardiology · 2024 · 54 citations · Full text

Medicine, Cardiology, Radiology +11

2020 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension

А. S. Galyavich, Sergey V. Gorbachevsky, N. M. Danilov et al. · Russian Journal of Cardiology · 2021 · 51 citations · Full text

Medicine, Cardiology, Surgery +10